Dyne Therapeutics (DYN) Preferred Shares Issued (2020)
Dyne Therapeutics (DYN) recorded quarterly Preferred Shares Issued of -$134000.0 in Q4 2020, down 106.8% quarter-over-quarter from $2.0 million in Q1 2020.
Dyne Therapeutics (DYN) Preferred Shares Issued (2020) Analysis & Trends
Dyne Therapeutics' Preferred Shares Issued history runs 1 years deep, the most recent figure standing at -$134000.0 for Q4 2020.
- In Q4 2020, Preferred Shares Issued changed N/A year-over-year to -$134000.0; the TTM figure through Dec 2020 stood at $1.8 million (changed N/A YoY), while the FY2020 annual figure was $134.8 million, up 574.3% from the prior year.
- Preferred Shares Issued was -$134000.0 for Q4 2020 at Dyne Therapeutics, down from $2.0 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $2.0 million in Q1 2020 to a low of -$134000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Dyne Therapeutics | 3.00 Bn | 3.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -134,000.00 |
| Dec 31, 2020 | -134,000.00 |
| Mar 31, 2020 | 1.97 Mn |
| Mar 31, 2020 | 1.97 Mn |